In a model of type 2 diabetes, a mix of live probiotics were able to reduce the expression of pro-apoptotic Bcl-2 and Caspase 3, while increasing levels of the anti-apoptotic protein Bax and inducing the PI3K/AKT pathway (37). This evidence concerns the gene BCL2 and type 2 diabetes mellitus.